Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Influenza
Pneumococcal disease
Risk group
Clear all
Type of publications
NITAG documentation
(6)
SAGE documentation
(2)
Topics
Regions
Americas
(3)
Europe
(3)
Countries
Belgium
(1)
Chile
(1)
France
(1)
United Kingdom
(1)
United States of America
(2)
Diseases
COVID-19
(5)
Influenza
(2)
Pneumococcal disease
(1)
Herpes zoster
(1)
Publication date
2022
(1)
2021
(2)
2020
(3)
2012
(2)
Target population
Risk group
(8)
Adolescents
(191)
Adults
(590)
All age groups
(580)
Children
(143)
Healthcare workers
(168)
Newborn
(97)
Older adults
(502)
Parents/caregivers
(43)
Pregnant women
(135)
Travellers
(3)
Available to download in languages
English (EN)
(4)
French (FR)
(2)
Spanish (ES)
(1)
8 results found
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against pneumococcal disease for adults in Belgium
2021
∙
JCVI
New COVID-19 vaccine advice for adults living with adults who are immunosuppressed
2021
∙
Haute Autorité de Santé
Update of risk factors for severe forms of Covid-19 and recommendations on the strategy for prioritizing populations to be vaccinated
2020
∙
CAVEI
CAVEI provisional recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
ACIP
COVID-19 vaccine prioritization: Work Group considerations
2020
∙
ACIP, Nancy McClung
Epidemiology of Individuals at Increased Risk of COVID-19 Disease
2012
∙
SAGE
Grading of scientific evidence for individuals with HIV/AIDS
2012
∙
SAGE
Grading of scientific evidence for patients with asthma
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register